{
    "table_name": "CPTAC.QUANT_PHOSPHOPROTEOME_AML_GILTERITINIB_RESISTANCE_PDC_CURRENT",
    "table_fullname": "CPTAC_PDC.CPTAC.QUANT_PHOSPHOPROTEOME_AML_GILTERITINIB_RESISTANCE_PDC_CURRENT",
    "column_names": [
        "sample_id",
        "aliquot_id",
        "refseq_id",
        "case_id",
        "aliquot_submitter_id",
        "protein_abundance_log2ratio",
        "phosphorylation_sites",
        "study_name",
        "aliquot_run_metadata_id"
    ],
    "column_types": [
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "FLOAT",
        "TEXT",
        "TEXT",
        "TEXT"
    ],
    "description": [
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null
    ],
    "sample_rows": [
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": 0.1474,
            "refseq_id": "NP_001014436.1",
            "phosphorylation_sites": "t291"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": 0.4626,
            "refseq_id": "NP_001093634.1",
            "phosphorylation_sites": "s533"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.9721,
            "refseq_id": "NP_001116314.1",
            "phosphorylation_sites": "s430"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.8697,
            "refseq_id": "NP_001138926.1",
            "phosphorylation_sites": "s46"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.9815,
            "refseq_id": "NP_001157616.1",
            "phosphorylation_sites": "s736"
        }
    ]
}